Your doctor will generally look at three specific areas: Your Health Metrics: Your doctor assesses individual markers like blood sugar levels, body mass index (BMI), and metabolic health to determine the duration and intensity of treatment
Of the two peptides only OXM was found to stimulate insulin secretion but its potency was too low to be of clinical benefit (Holst 2024
International journal of physiology, pathophysiology and pharmacology, 10(3), 132138 Santra, M., Zhang, Z
In the trials, the most common were: Nausea Diarrhea Constipation Vomiting These effects were usually mild to moderate and tended to show up early in the first few weeks of treatment or right after a dose increase
Computational identification of a transiently open L1/S3 pocket for reactivation of mutantp53
Another strategy to prolong the duration of action of GLP-1 receptor agonists is to covalently fuse them to a larger protein